There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to seek FDA approval for Cervarix by the end of the year.

Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is ...

The HPV vaccines Gardasil and Cervarix can effectively prevent infections from the most dangerous HPV strains associated with cancer development. However, timing proves critical when it comes to ...

have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16 ...

Vaccine efficacy of 100% was observed against HPV-16/18-related cervical intraepithelial ... integrated safety analyses show that Cervarix has a favorable safety profile in diverse populations ...

HPV vaccines are safe and protect against many types of cancer including cervical, throat, and anal. Common HPV vaccine side effects should subside in 2 days and include dizziness, nausea ...

It was also caused by the human papillomavirus, or HPV. The treatment was brutal ... the Gardasil and Cervarix vaccines. Administered before a child risks exposure through sex, they not only ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer cases ...

Safety documentation is a priority in all phases of the vaccine clinical trials. Safety is categorized as local reactions from the injection itself and as systemic reactions that may occur ...